C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 491/113 (2006.01) A61K 31/438 (2006.01) A61P 9/00 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2674958
The present invention is concerned with novel spiropiperidine glycinamide derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases. In particular, the present invention is concerned with compounds of the general formula (I) wherein X, Y and R1 to R10 are as described herein.
La présente invention concerne des dérivés innovants de spiropipéridine glycinamide en tant qu'antagonistes du récepteur V1a, leur fabrication, les compositions pharmaceutiques qui les contiennent et leur utilisation en tant que médicaments. Les composés actifs de la présente invention sont utilisables pour la prévention et/ou le traitement de l'anxiété et des troubles dépressifs et d'autres maladies. La présente invention concerne en particulier des composés de formule générale (I) dans laquelle X, Y et R1 à R10 sont tels que décrits ici.
Bissantz Caterina
Goetschi Erwin
Grundschober Christophe
Masciadri Raffaello
Ratni Hasane
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Spiropiperidine glycinamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiropiperidine glycinamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiropiperidine glycinamide derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1646118